Vaccine and Clinical Trials

Advancements of Vaccines

Submit Abstract Register Now

Vaccinations have the power to improve people’s chances of survival, protect communities from new and reemerging infectious diseases, and enhance societal productivity.  With every new technological advancement and more clinical trials, we can extend the benefits of vaccines to more people and provide more protection. Five recent developments contributing to the advancement in vaccines are faster sequencing, synthetic generation, use of artificial intelligence (AI), researching more on mRNA and DNA vaccines. Using recombinant technology, single-use technology, continuous manufacturing, use of animal-free components are the latest trends in the manufacturing of vaccines.

Related associations and societies: National Institutes of Health (NIH), Federation of Clinical Immunology Societies (FOCIS), Immune Deficiency Foundation (IDF),  Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI), Clinical Immunology Society, Hepatitis B Foundation (HBF), National Institute of Allergy and Infectious Diseases (NIAID), Pediatric Infectious Diseases Society(PIDS), Indian Vaccine Manufacturers Association (IVMA), National Medical Association (NMA)